Clinical characteristics, bacterial coinfections and outcomes in COVID-19-associated pulmonary aspergillosis in a third-level Mexican hospital during the COVID-19 pre-vaccination era.

Autor: Hernández-Silva G; Infectious Diseases Department, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico., Corzo-León DE; MRC Medical Mycology Centre at University of Exeter, Exeter, UK., Becerril-Vargas E; Microbiology Clinical Laboratory, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico., Peralta-Prado AB; Research Centre of Infectious Diseases, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico., Odalis RG; Pharmacology Department, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico., Morales-Villarreal F; Microbiology Clinical Laboratory, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico., Ríos-Ayala MA; Intensive Care Unit, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico., Alonso TG; Pneumology Service, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico., Agustín FD; Pneumology Service, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico., Ramón AF; Pneumology Service, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico., Hugo AV; Infectious Diseases Department, Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico.

Publikováno v: Mycoses [Mycoses] 2024 Jan; Vol. 67 (1), pp. e13693.